Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J CURIEL

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Experimental Gerontology|February 7, 2018
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effectsEllen Kraig, Leslie A Linehan, Hanyu Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian CancerSuzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, et al.
Oncotarget|June 22, 2016
Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancerBin Yuan, Long Cheng, Kshama Gupta, et al.
Cancer Medicine|February 24, 2021
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapyDeyi Zhang, Ryan M Reyes, Erica Osta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.
Cancer Immunology Research|December 20, 2018
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder CancerRobert S Svatek, Niannian Ji, Essel de Leon, et al.
Cancer Research|April 13, 2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged miceVincent Hurez, Benjamin J Daniel, Lishi Sun, et al.
Biogeosciences (Online)|January 8, 2013
Soil respiration at mean annual temperature predicts annual total across vegetation types and biomesM Bahn, M Reichstein, E A Davidson, et al.
Cancer Discovery|October 4, 2016
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor CellsNikolaos Svoronos, Alfredo Perales-Puchalt, Michael J Allegrezza, et al.
Cancer Research|September 28, 2016
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and MelanomaCurtis A Clark, Harshita B Gupta, Gangadhara Sareddy, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Experimental Gerontology|February 7, 2018
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effectsEllen Kraig, Leslie A Linehan, Hanyu Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian CancerSuzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, et al.
Oncotarget|June 22, 2016
Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancerBin Yuan, Long Cheng, Kshama Gupta, et al.
Cancer Medicine|February 24, 2021
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapyDeyi Zhang, Ryan M Reyes, Erica Osta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.
Cancer Immunology Research|December 20, 2018
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder CancerRobert S Svatek, Niannian Ji, Essel de Leon, et al.
Cancer Research|April 13, 2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged miceVincent Hurez, Benjamin J Daniel, Lishi Sun, et al.
Biogeosciences (Online)|January 8, 2013
Soil respiration at mean annual temperature predicts annual total across vegetation types and biomesM Bahn, M Reichstein, E A Davidson, et al.
Cancer Discovery|October 4, 2016
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor CellsNikolaos Svoronos, Alfredo Perales-Puchalt, Michael J Allegrezza, et al.
Cancer Research|September 28, 2016
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and MelanomaCurtis A Clark, Harshita B Gupta, Gangadhara Sareddy, et al.
Pageof 15